GALD.SW
GALD.SW
CH1335392721
GALDERMA GROUP N
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 5.241.000.000 4.440.000.000
18.0%
Cost of Revenue 1.632.000.000 1.355.000.000
20.4%
Gross Profit 3.609.000.000 3.085.000.000
17.0%
2.733.000.000 2.407.000.000
13.5%
Operating Income 876.000.000 678.000.000
29.2%
Pretax Income 638.000.000 310.000.000
105.8%
Net Income Common Stockholders 613.000.000 231.000.000
165.4%
-- --
--
-- --
--
ende